Cargando…

The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease

Detalles Bibliográficos
Autores principales: Sinha, Smeeta, Chiu, Diana Y. Y., Peebles, George, Kolakkat, Shabeer, Lamerton, Elizabeth, Fenwick, Sean, Kalra, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421402/
https://www.ncbi.nlm.nih.gov/pubmed/25949371
http://dx.doi.org/10.1093/ndtplus/sfp073
_version_ 1782369861020680192
author Sinha, Smeeta
Chiu, Diana Y. Y.
Peebles, George
Kolakkat, Shabeer
Lamerton, Elizabeth
Fenwick, Sean
Kalra, Philip A.
author_facet Sinha, Smeeta
Chiu, Diana Y. Y.
Peebles, George
Kolakkat, Shabeer
Lamerton, Elizabeth
Fenwick, Sean
Kalra, Philip A.
author_sort Sinha, Smeeta
collection PubMed
description
format Online
Article
Text
id pubmed-4421402
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44214022015-05-06 The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease Sinha, Smeeta Chiu, Diana Y. Y. Peebles, George Kolakkat, Shabeer Lamerton, Elizabeth Fenwick, Sean Kalra, Philip A. NDT Plus Letter Oxford University Press 2009-10 2009-06-17 /pmc/articles/PMC4421402/ /pubmed/25949371 http://dx.doi.org/10.1093/ndtplus/sfp073 Text en © The Author [2009]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter
Sinha, Smeeta
Chiu, Diana Y. Y.
Peebles, George
Kolakkat, Shabeer
Lamerton, Elizabeth
Fenwick, Sean
Kalra, Philip A.
The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
title The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
title_full The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
title_fullStr The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
title_full_unstemmed The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
title_short The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
title_sort safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421402/
https://www.ncbi.nlm.nih.gov/pubmed/25949371
http://dx.doi.org/10.1093/ndtplus/sfp073
work_keys_str_mv AT sinhasmeeta thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT chiudianayy thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT peeblesgeorge thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT kolakkatshabeer thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT lamertonelizabeth thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT fenwicksean thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT kalraphilipa thesafetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT sinhasmeeta safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT chiudianayy safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT peeblesgeorge safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT kolakkatshabeer safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT lamertonelizabeth safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT fenwicksean safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease
AT kalraphilipa safetyofacceleratedinfusionversusstandardrateinfusionoflowmolecularweightirondextraninpatientswithchronickidneydisease